The Tecnis multifocal intraocular lens (IOL) has been approved by the FDA, according to an announcement made by AMO, the manufacturer of the lens.
The Tecnis multifocal intraocular lens (IOL) has been approved by the FDA, according to an announcement made by AMO, the manufacturer of the lens.
Tecnis is indicated to correct aphakia in adult patients with or without presbyopia following phacoemulsification. The lens provides high quality near, intermediate and distance vision in a range of light conditions (both day and night) for 94% of patients. It has a pupil-independent, non-apodized diffractive aspheric surface to reduce chromatic aberration, and almost nine out of every 10 patients implanted with the lens were found to be spectacle-independent after surgery.
The multifocal, which is already available in Europe, will be available to surgeons in the US sometime early this year.
